TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW
PRESS RELEASES

Crescita Announces Licensing Agreement For Pliaglis® In China

  • By PR Newswire
  • Nov 5, 2020 7:30 AM EST
PRESS RELEASES

Crescita To Receive One-time Cash Payment Following Amendment To Pliaglis® U.S. Licensing Agreement

  • By PR Newswire
  • Jul 28, 2020 7:30 AM EDT
PRESS RELEASES

Crescita Therapeutics Announces Extension Of First Quarter 2020 Filings Due To COVID-19

  • By PR Newswire
  • Apr 28, 2020 5:58 PM EDT
PRESS RELEASES

Crescita Therapeutics Announces Measures In Response To COVID-19 Virus

  • By PR Newswire
  • Mar 24, 2020 7:23 PM EDT
PRESS RELEASES

Crescita Announces Positive Topline Results From Two Pivotal Phase 3 Clinical Studies For Its Lead Pipeline Product In Patients With Plaque Psoriasis

  • By PR Newswire
  • Feb 11, 2020 7:30 AM EST
PRESS RELEASES

Crescita Awarded Cannabis Research License From Health Canada

  • By PR Newswire
  • Jan 24, 2020 7:30 AM EST
PRESS RELEASES

Crescita Secures Line Of Credit With The Royal Bank Of Canada Following Repayment In Full Of Knight Therapeutics Loan

  • By PR Newswire
  • Jan 22, 2020 7:30 AM EST
PRESS RELEASES

Crescita Signs Exclusive Distribution Agreement With FILLMED

  • By PR Newswire
  • Jan 20, 2020 7:30 AM EST
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.